These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34806537)

  • 21. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ram FS; Cates CJ; Ducharme FM
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.
    Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ
    Cochrane Database Syst Rev; 2010 Apr; (4):CD005533. PubMed ID: 20393943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.
    Sobieraj DM; Weeda ER; Nguyen E; Coleman CI; White CM; Lazarus SC; Blake KV; Lang JE; Baker WL
    JAMA; 2018 Apr; 319(14):1485-1496. PubMed ID: 29554195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "As-Needed" Inhaled Corticosteroids for Patients With Asthma.
    Cardet JC; Papi A; Reddel HK
    J Allergy Clin Immunol Pract; 2023 Mar; 11(3):726-734. PubMed ID: 36702246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
    Reddel HK; Bacharier LB; Bateman ED; Brightling CE; Brusselle GG; Buhl R; Cruz AA; Duijts L; Drazen JM; FitzGerald JM; Fleming LJ; Inoue H; Ko FW; Krishnan JA; Levy ML; Lin J; Mortimer K; Pitrez PM; Sheikh A; Yorgancioglu AA; Boulet LP
    Respirology; 2022 Jan; 27(1):14-35. PubMed ID: 34668278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. As-Needed Use of Short-Acting β
    Rodríguez-Martínez CE; Sossa-Briceño MP; Buendia JA
    J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1562-1568. PubMed ID: 35259534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy.
    Buhl R; Kuna P; Peters MJ; Andersson TL; Naya IP; Peterson S; Rabe KF
    Respir Res; 2012 Jul; 13(1):59. PubMed ID: 22816878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SMART for the treatment of asthma: A network meta-analysis of real-world evidence.
    Rogliani P; Beasley R; Cazzola M; Calzetta L
    Respir Med; 2021 Nov; 188():106611. PubMed ID: 34536699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S; Vogelmeier C; Buhl R
    Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma.
    Kew KM; Dahri K
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011721. PubMed ID: 26798035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beginning to Address an Implementation Gap in Asthma: Clinicians' Views of Prescribing Reliever Budesonide-Formoterol Inhalers and SMART in the United States.
    Krings JG; Sekhar TC; Chen V; Blake KV; Sumino K; James AS; Clover AK; Lenze EJ; Brownson RC; Castro M
    J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2767-2777. PubMed ID: 37245736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials.
    Hatter L; Houghton C; Bruce P; Holliday M; Eathorne A; Pavord I; Reddel HK; Hancox RJ; Braithwaite I; Oldfield K; Papi A; Weatherall M; Beasley R;
    BMJ Open Respir Res; 2022 Aug; 9(1):. PubMed ID: 36007980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expert Opinion on Practice Patterns in Mild Asthma After the GINA 2019 Updates: A Major Shift in Treatment Paradigms from a Long-Standing SABA-Only Approach to a Risk Reduction-Based Strategy with the Use of Symptom-Driven (As-Needed) Low-Dose ICS/LABA.
    Ozseker ZF; Aksu K; Mutlu LC; Mutlu P; Ozturk C;
    Curr Allergy Asthma Rep; 2022 Oct; 22(10):123-134. PubMed ID: 35689764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review.
    Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TSC
    BMJ Evid Based Med; 2022 Jun; 27(3):178-184. PubMed ID: 34282031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children.
    Ni Chroinin M; Greenstone I; Lasserson TJ; Ducharme FM
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD005307. PubMed ID: 19821344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SABAs as Reliever Medications in Asthma Management: Evidence-Based Science.
    Amirav I; Garcia G; Le BK; Barria P; Levy G; Aggarwal B; Fahrbach K; Martin A; Phansalkar A; Sriprasart T
    Adv Ther; 2023 Jul; 40(7):2927-2943. PubMed ID: 37280414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.
    Chauhan BF; Jeyaraman MM; Singh Mann A; Lys J; Abou-Setta AM; Zarychanski R; Ducharme FM
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010347. PubMed ID: 28301050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.